Tvardi Therapeutics (TVRD) Financial Statements

Tvardi Therapeutics's market cap is currently $41.17M. The company's EPS TTM is $-46.639; its P/E ratio is -0.25; Tvardi Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.